111 related articles for article (PubMed ID: 7864932)
1. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans' cell histiocytosis.
López-Andreu JA; Ferris J; Verdeguer A; Esquembre C; Castel V
Cancer; 1994 Sep; 74(5):1650-2. PubMed ID: 7864932
[No Abstract] [Full Text] [Related]
2. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
Egeler RM
Cancer; 1995 Jan; 75(1):134-6. PubMed ID: 7804969
[No Abstract] [Full Text] [Related]
3. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S
Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489
[TBL] [Abstract][Full Text] [Related]
4. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations.
Haupt R; Fears TR; Heise A; Gadner H; Loiacono G; De Terlizzi M; Tucker MA
Int J Cancer; 1997 Mar; 71(1):9-13. PubMed ID: 9096658
[TBL] [Abstract][Full Text] [Related]
5. Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis.
Matsuzaki A; Inamitsu T; Watanabe T; Ohga S; Ishii E; Nagotoshi Y; Tasaka H; Suda M; Ueda K
Br J Haematol; 1994 Apr; 86(4):887-9. PubMed ID: 7918090
[TBL] [Abstract][Full Text] [Related]
6. Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH).
Lopes LF; de Camargo B
Med Pediatr Oncol; 1999 Apr; 32(4):315. PubMed ID: 10102032
[No Abstract] [Full Text] [Related]
7. Chromosomal localization of the APL t(15;17) breakpoints by molecular cytogenetic analysis.
Donti E; Longo L; Pelicci PG
Cancer Genet Cytogenet; 1991 Jul; 54(2):265-6. PubMed ID: 1884363
[No Abstract] [Full Text] [Related]
8. Molecular analysis of the t(15;17) translocation in de novo and secondary acute promyelocytic leukemia.
Naoe T; Kudo K; Yoshida H; Horibe K; Ohno R
Leukemia; 1997 Apr; 11 Suppl 3():287-8. PubMed ID: 9209367
[TBL] [Abstract][Full Text] [Related]
9. The genetic characterization of acute promyelocytic leukemia with cryptic t(15;17) including a new recurrent additional cytogenetic abnormality i(17)(q10).
Kim M; Lim J; Kim Y; Han K; Lee DH; Chung NG; Cho B; Kim HK; Eom KS; Min CK; Min WS
Leukemia; 2008 Apr; 22(4):881-3. PubMed ID: 17943164
[No Abstract] [Full Text] [Related]
10. [Therapy-related acute promyelocytic leukemia with a t(9;22)(q34;q11) and t(15;17)(q22;q11 to approximately 12) subclone].
Mochiduki Y; Muramoto S
Rinsho Ketsueki; 2005 Nov; 46(11):1218-22. PubMed ID: 16440807
[TBL] [Abstract][Full Text] [Related]
11. [Simultaneous presence of ins(17;15) and t(11;19) in a patient with acute promyelocytic leukemia].
Zhou J; Gui R; Zu Y; Wang Q; Zhou H; Zhang Y; Wei X; Song Y
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):294. PubMed ID: 24759014
[No Abstract] [Full Text] [Related]
12. Acute myeloid leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis of bone.
Haupt R; Comelli A; Rosanda C; Sessarego M; De Bernardi B
Am J Pediatr Hematol Oncol; 1993 May; 15(2):255-7. PubMed ID: 8498650
[TBL] [Abstract][Full Text] [Related]
13. Identification of ider[17q] in addition to t[15;17] in acute promyelocytic leukemia using whole chromosome painting probes made by interspecies hybrid using inter-Alu PCR.
Im SA; Kim SH; Lee MA; Ahn JY; Yoo ES; Choi DY; Lee JY; Lee S; Huh JW; Chung WS; Lee SN; Seong CM
Cancer Genet Cytogenet; 2000 Apr; 118(2):169-70. PubMed ID: 10798868
[No Abstract] [Full Text] [Related]
14. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
Slack JL; Arthur DC; Lawrence D; Mrózek K; Mayer RJ; Davey FR; Tantravahi R; Pettenati MJ; Bigner S; Carroll AJ; Rao KW; Schiffer CA; Bloomfield CD
J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186
[TBL] [Abstract][Full Text] [Related]
15. Etoposide-related acute promyelocytic leukemia.
Kudo K; Yoshida H; Kiyoi H; Numata S; Horibe K; Naoe T
Leukemia; 1998 Aug; 12(8):1171-5. PubMed ID: 9697869
[TBL] [Abstract][Full Text] [Related]
16. Derivative (7)t(7;8)(q34;q21): an additional chromosome aberration in acute promyelocytic leukemia-prognostic influence debated.
Haimi M; Elhasid R; Weyl Ben-Arush M; Brill-Zamir R; Laevski I; Gershoni-Baruch R
Cancer Genet Cytogenet; 2004 Aug; 153(1):81-3. PubMed ID: 15325101
[No Abstract] [Full Text] [Related]
17. Acute promyelocytic leukemia after treatment for non-Hodgkin's lymphoma with drugs targeting topoisomerase II.
De Renzo A; Santoro LF; Notaro R; Pane F; Buonaiuto MR; Luciano L; Rotoli B
Am J Hematol; 1999 Apr; 60(4):300-4. PubMed ID: 10203104
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia with a dicentric chromosome involving chromosomes 11, 17, and 18.
Chong YY; Wong GC; Lau LC; Knight L; Lim P; Lui WO; Yong MH; Goh YT; Tan P
Cancer Genet Cytogenet; 1998 Aug; 105(1):69-73. PubMed ID: 9689933
[TBL] [Abstract][Full Text] [Related]
19. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
[TBL] [Abstract][Full Text] [Related]
20. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
Dalal BI; Bruyere H; Barnett MJ
Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
[No Abstract] [Full Text] [Related]
[Next] [New Search]
